Focal nodular hyperplasiaK76.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

FNH; Focalnodular hyperplasia; Focal nodular hyperplasia of the liver

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Edmondson, 1958

DefinitionThis section has been translated automatically.

Focal, polyclonal, non-specific hyperplasia of hepatocytes. Second most frequent benign liver tumor (Marrero JA et al. 2014).

EtiopathogenesisThis section has been translated automatically.

Focal-nodular hyperplasia is defined as a hamartoma (malformation) of the liver. Apparently, however, hyperplasia can also occur reactively.

In 60 % of patients focal-nodular hyperplasia develops with the use of oral anticonceptives. Pathogenetically, the relationship between the intake of estrogen-containing preparations and the development or increase in size growth is not fully understood (Chandrasegaram MD et al. 2015). Stopping hormone therapy can lead to regression.

A vascular malformation is also being discussed. Some authors interpret FNH as "hyperplastic-regenerative reaction in liver tissue to regionally increased perfusion" through isolated large-caliber arteries (Wanless et al. 1985). Such processes are known to occur in vascular malformations of other organs.

As triggering factors, various other factors have also been identified. Drugs such as thiopurines, various other chemotherapeutic agents and antiretroviral drugs have been described as triggering factors (Ghabril M et al. 2014).

ManifestationThis section has been translated automatically.

Women between the ages of 20 and 50 are particularly affected.

Clinical featuresThis section has been translated automatically.

As a rule, these are solitary nodes (multifocal FNH is described) with a diameter < 5 cm. Mostly discovered as a random finding in imaging procedures (ultrasound, CT, MRI), which were induced for other reasons. In the contrast medium sonogram evidence of a central artery with wheel spoke structure of the parenchyma. Only rarely is the FHA clinically conspicuous due to its size with upper abdominal pain.

LaboratoryThis section has been translated automatically.

Possibly slight increase in liver values.

DiagnosisThis section has been translated automatically.

The most widely used sonography is basically the primary imaging procedure of diagnostic examination sequences. The combination of contrast medium-supported computer tomography with sonography can be used for further confirmatory imaging diagnostics. Only rarely is histological clarification necessary.

Complication(s)This section has been translated automatically.

In extremely rare cases, bleeding or rupture of an FNH may occur.

Progression/forecastThis section has been translated automatically.

Malignancy is not described by the FNH. Surgical removal is only necessary in case of very large nodules (>5cm) or in case of severe abdominal pain.

Note(s)This section has been translated automatically.

Increased concordant occurrence with vascular anomalies such as: telangiectasias, arteriovenous fistulas, Osler's disease, congenital portocaval anastomoses (in patients with congenital portocaval anastomosis, cases with an FN are increasingly observed), hemangiomas (Wanless et al. 1989)

LiteratureThis section has been translated automatically.

  1. Chandrasegaram MD et al (2015) Estrogen hormone receptors in focal nodular hyperplasia. HPB (Oxford) 17:502-507.
  2. Ghabril M et al (2014) Drug-induced nodular regenerative hyperplasia. Semin Liver Dis 34:240-245.
  3. Marrero JA et al (2014) ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 109:1328-1347
  4. Wanless IR et al (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5: 1194-1200
  5. Wanless IR et al (1989) Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 2: 456-462.

Authors

Last updated on: 29.10.2020